[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 68, "title": "Executive Chairman", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 43, "title": "CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betsy  Gutierrez", "title": "Senior Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.27, "open": 1.95, "dayLow": 1.83, "dayHigh": 2.07, "regularMarketPreviousClose": 2.27, "regularMarketOpen": 1.95, "regularMarketDayLow": 1.83, "regularMarketDayHigh": 2.07, "payoutRatio": 0.0, "forwardPE": -2.0, "volume": 6353044, "regularMarketVolume": 6353044, "averageVolume": 17084914, "averageVolume10days": 18577160, "averageDailyVolume10Day": 18577160, "bid": 1.98, "ask": 2.04, "bidSize": 25, "askSize": 25, "marketCap": 247724272, "fiftyTwoWeekLow": 0.387, "fiftyTwoWeekHigh": 3.87, "allTimeHigh": 36.27, "allTimeLow": 0.387, "priceToSalesTrailing12Months": 206.43689, "fiftyDayAverage": 1.00022, "twoHundredDayAverage": 0.96262, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9442260, "profitMargins": 0.0, "floatShares": 25895, "sharesOutstanding": 97541221, "sharesShort": 118781, "sharesShortPriorMonth": 63982, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0025, "heldPercentInsiders": 0.059, "heldPercentInstitutions": 0.27703, "shortRatio": 0.37, "shortPercentOfFloat": 0.0031, "impliedSharesOutstanding": 122635774, "bookValue": -109.302, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -28315000, "trailingEps": -0.9, "forwardEps": -1.01, "enterpriseToRevenue": 7.869, "enterpriseToEbitda": -0.236, "52WeekChange": -0.22900766, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 2.02, "targetHighPrice": 11.0, "targetLowPrice": 8.0, "targetMeanPrice": 9.5, "targetMedianPrice": 9.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 4144000, "totalCashPerShare": 57.627, "ebitda": -40039000, "totalDebt": 17554000, "quickRatio": 0.216, "currentRatio": 0.259, "totalRevenue": 1200000, "revenuePerShare": 0.032, "returnOnAssets": -0.95518994, "grossProfits": 1200000, "freeCashflow": -9124375, "operatingCashflow": -27663000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -34.1825, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 1.01978, "fiftyDayAverageChangePercent": 1.0195558, "twoHundredDayAverageChange": 1.05738, "twoHundredDayAverageChangePercent": 1.0984396, "priceToBook": -0.018480906, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": -8.41584, "postMarketPrice": 1.85, "postMarketChange": -0.16999996, "regularMarketChange": -0.25, "regularMarketDayRange": "1.83 - 2.07", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 17084914, "corporateActions": [], "postMarketTime": 1762563599, "regularMarketTime": 1762549200, "regularMarketChangePercent": -11.0132, "regularMarketPrice": 2.02, "fiftyTwoWeekLowChange": 1.633, "fiftyTwoWeekLowChangePercent": 4.2196383, "fiftyTwoWeekRange": "0.387 - 3.87", "fiftyTwoWeekHighChange": -1.8499999, "fiftyTwoWeekHighChangePercent": -0.47803617, "fiftyTwoWeekChangePercent": -22.900766, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.9, "epsForward": -1.01, "epsCurrentYear": -0.49, "priceEpsCurrentYear": -4.122449, "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]